154 related articles for article (PubMed ID: 9234754)
1. Genetic control of antibody responses induced by recombinant Mycobacterium bovis BCG expressing a foreign antigen.
Lagranderie M; Lo-Man R; Dériaud E; Gicquel B; Gheorghiu M; Leclerc C
Infect Immun; 1997 Aug; 65(8):3057-64. PubMed ID: 9234754
[TBL] [Abstract][Full Text] [Related]
2. Mycobacterium bovis BCG priming induces a strong potentiation of the antibody response induced by recombinant BCG expressing a foreign antigen.
Gheorghiu M; Lagranderie MR; Gicquel BM; Leclerc CD
Infect Immun; 1994 Oct; 62(10):4287-95. PubMed ID: 7927686
[TBL] [Abstract][Full Text] [Related]
3. Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains.
Lagranderie MR; Balazuc AM; Deriaud E; Leclerc CD; Gheorghiu M
Infect Immun; 1996 Jan; 64(1):1-9. PubMed ID: 8557324
[TBL] [Abstract][Full Text] [Related]
4. Development of BCG as a live recombinant vector system: potential use as an HIV vaccine.
Fuerst TR; Stover CK; de la Cruz VF
Biotechnol Ther; 1991; 2(1-2):159-78. PubMed ID: 1845119
[TBL] [Abstract][Full Text] [Related]
5. Recombinant BCG as an antigen delivery system.
Flynn JL
Cell Mol Biol (Noisy-le-grand); 1994; 40 Suppl 1():31-6. PubMed ID: 7950859
[TBL] [Abstract][Full Text] [Related]
6. A recombinant BCG vaccine generates a Th1-like response and inhibits IgE synthesis in BALB/c mice.
Kumar M; Behera AK; Matsuse H; Lockey RF; Mohapatra SS
Immunology; 1999 Jul; 97(3):515-21. PubMed ID: 10447775
[TBL] [Abstract][Full Text] [Related]
7. Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine.
Stover CK; Bansal GP; Hanson MS; Burlein JE; Palaszynski SR; Young JF; Koenig S; Young DB; Sadziene A; Barbour AG
J Exp Med; 1993 Jul; 178(1):197-209. PubMed ID: 8315378
[TBL] [Abstract][Full Text] [Related]
8. Recombinant Mycobacterium bovis BCG expressing pertussis toxin subunit S1 induces protection against an intracerebral challenge with live Bordetella pertussis in mice.
Nascimento IP; Dias WO; Mazzantini RP; Miyaji EN; Gamberini M; Quintilio W; Gebara VC; Cardoso DF; Ho PL; Raw I; Winter N; Gicquel B; Rappuoli R; Leite LC
Infect Immun; 2000 Sep; 68(9):4877-83. PubMed ID: 10948100
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
Deng YH; He HY; Zhang FJ
Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
[TBL] [Abstract][Full Text] [Related]
10. Oral immunization with recombinant BCG induces cellular and humoral immune responses against the foreign antigen.
Lagranderie M; Murray A; Gicquel B; Leclerc C; Gheorghiu M
Vaccine; 1993 Oct; 11(13):1283-90. PubMed ID: 8296480
[TBL] [Abstract][Full Text] [Related]
11. Induction of neutralizing antibodies against diphtheria toxin by priming with recombinant Mycobacterium bovis BCG expressing CRM(197), a mutant diphtheria toxin.
Miyaji EN; Mazzantini RP; Dias WO; Nascimento AL; Marcovistz R; Matos DS; Raw I; Winter N; Gicquel B; Rappuoli R; Leite LC
Infect Immun; 2001 Feb; 69(2):869-74. PubMed ID: 11159980
[TBL] [Abstract][Full Text] [Related]
12. A Combination of Recombinant Mycobacterium bovis BCG Strains Expressing Pneumococcal Proteins Induces Cellular and Humoral Immune Responses and Protects against Pneumococcal Colonization and Sepsis.
Goulart C; Rodriguez D; Kanno AI; Converso TR; Lu YJ; Malley R; Leite LCC
Clin Vaccine Immunol; 2017 Oct; 24(10):. PubMed ID: 28768668
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant activity of Mycobacterium bovis BCG expressing CRM197 on the immune response induced by BCG expressing tetanus toxin fragment C.
Mazzantini RP; Miyaji EN; Dias WO; Sakauchi D; Nascimento AL; Raw I; Winter N; Gicquel B; Rappuoli R; Leite LC
Vaccine; 2004 Jan; 22(5-6):740-6. PubMed ID: 14741167
[TBL] [Abstract][Full Text] [Related]
14. A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis.
Skinner MA; Ramsay AJ; Buchan GS; Keen DL; Ranasinghe C; Slobbe L; Collins DM; de Lisle GW; Buddle BM
Immunology; 2003 Apr; 108(4):548-55. PubMed ID: 12667217
[TBL] [Abstract][Full Text] [Related]
15. BCG-induced mucosal immune responses.
Gheorghiu M
Int J Immunopharmacol; 1994; 16(5-6):435-44. PubMed ID: 7927990
[TBL] [Abstract][Full Text] [Related]
16. Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines.
Aldovini A; Young RA
Nature; 1991 Jun; 351(6326):479-82. PubMed ID: 2046750
[TBL] [Abstract][Full Text] [Related]
17. Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity.
Luo Y; Yamada H; Chen X; Ryan AA; Evanoff DP; Triccas JA; O'Donnell MA
Clin Exp Immunol; 2004 Jul; 137(1):24-34. PubMed ID: 15196240
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
[TBL] [Abstract][Full Text] [Related]
19. Recombinant Mycobacterium bovis BCG producing the circumsporozoite protein of Plasmodium falciparum FCC-1/HN strain induces strong immune responses in BALB/c mice.
Zheng C; Xie P; Chen Y
Parasitol Int; 2002 Mar; 51(1):1-7. PubMed ID: 11880222
[TBL] [Abstract][Full Text] [Related]
20. New use of BCG for recombinant vaccines.
Stover CK; de la Cruz VF; Fuerst TR; Burlein JE; Benson LA; Bennett LT; Bansal GP; Young JF; Lee MH; Hatfull GF
Nature; 1991 Jun; 351(6326):456-60. PubMed ID: 1904554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
